No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19

BACKGROUND: The use of hydroxychloroquine (HCQ), with or without concurrent administration of azithromycin (AZM), for treatment of COVID-19 has received considerable attention. The purpose of this study was to determine whether HCQ administration is associated with improved mortality in COVID-19 pat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Infect Dis
Auteurs principaux: Sands, Kenneth, Wenzel, Richard, McLean, Laura, Korwek, Kimberly, Roach, Jonathon, Miller, Karla, Poland, Russell E., Burgess, L. Hayley, Jackson, Edmund, Perlin, Jonathan B.
Format: Artigo
Langue:Inglês
Publié: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7834474/
https://ncbi.nlm.nih.gov/pubmed/33359949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.12.060
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires